Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Munck

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Ugeskrift for Laeger|August 7, 1989
[A study of percutaneous absorption of estradiol and progesterone in absolute alcohol in postmenopausal women]L G Madsen, A M Munck, O D Pedersen, et al.
Biochemical and Biophysical Research Communications|August 26, 1998
ADD1/SREBP-1c mediates insulin-induced gene expression linked to the MAP kinase pathwayJ Kotzka, D Müller-Wieland, A Koponen, et al.
Acta Oncologica (Stockholm, Sweden)|August 12, 2004
Quality assurance of patient dosimetry in boron neutron capture therapyPer M Munck af Rosenschöld, Jacek Capala, Crister P Ceberg, et al.
Communications Biology|April 24, 2025
The identification of functional regions of MEK1 using CRISPR tiling screensZhiqiang Zhang, Barbara Abreu, Jessica L Brothwood, et al.
International Journal of Cancer|December 2, 1992
Growth of Hodgkin cell lines in severely combined immunodeficient miceC von Kalle, J Wolf, A Becker, et al.
Molecular Cancer Therapeutics|November 22, 2019
Dual-Mechanism ERK1/2 Inhibitors Exploit a Distinct Binding Mode to Block Phosphorylation and Nuclear Accumulation of ERK1/2Andrew M Kidger, Joanne M Munck, Harpreet K Saini, et al.
Molecular Cancer Therapeutics|October 29, 2014
Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma modelsTomoko Smyth, Kim H T Paraiso, Keisha Hearn, et al.
Medical Physics|February 16, 2006
An international dosimetry exchange for boron neutron capture therapy. Part I: Absorbed dose measurementsP J Binns, K J Riley, O K Harling, et al.
Molecular Cancer Therapeutics|April 27, 2018
ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor GrowthGeorge A Ward, Edward J Lewis, Jong Sook Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survivalLiam Cornell, Joanne M Munck, Clara Alsinet, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Ugeskrift for Laeger|August 7, 1989
[A study of percutaneous absorption of estradiol and progesterone in absolute alcohol in postmenopausal women]L G Madsen, A M Munck, O D Pedersen, et al.
Biochemical and Biophysical Research Communications|August 26, 1998
ADD1/SREBP-1c mediates insulin-induced gene expression linked to the MAP kinase pathwayJ Kotzka, D Müller-Wieland, A Koponen, et al.
Acta Oncologica (Stockholm, Sweden)|August 12, 2004
Quality assurance of patient dosimetry in boron neutron capture therapyPer M Munck af Rosenschöld, Jacek Capala, Crister P Ceberg, et al.
Communications Biology|April 24, 2025
The identification of functional regions of MEK1 using CRISPR tiling screensZhiqiang Zhang, Barbara Abreu, Jessica L Brothwood, et al.
International Journal of Cancer|December 2, 1992
Growth of Hodgkin cell lines in severely combined immunodeficient miceC von Kalle, J Wolf, A Becker, et al.
Molecular Cancer Therapeutics|November 22, 2019
Dual-Mechanism ERK1/2 Inhibitors Exploit a Distinct Binding Mode to Block Phosphorylation and Nuclear Accumulation of ERK1/2Andrew M Kidger, Joanne M Munck, Harpreet K Saini, et al.
Molecular Cancer Therapeutics|October 29, 2014
Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma modelsTomoko Smyth, Kim H T Paraiso, Keisha Hearn, et al.
Medical Physics|February 16, 2006
An international dosimetry exchange for boron neutron capture therapy. Part I: Absorbed dose measurementsP J Binns, K J Riley, O K Harling, et al.
Molecular Cancer Therapeutics|April 27, 2018
ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor GrowthGeorge A Ward, Edward J Lewis, Jong Sook Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survivalLiam Cornell, Joanne M Munck, Clara Alsinet, et al.
Pageof 4